bromopyruvate has been researched along with glycogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallardo-Pérez, JC; García-García, JD; Gracia-Mora, I; López-Ramírez, SY; Macías-Silva, M; Marín-Hernández, A; Moreno-Sánchez, R; Rodríguez-Enríquez, S; Rodríguez-Zavala, JS; Ruiz-Ramírez, L; Sosa-Garrocho, M; Zentella-Dehesa, A | 1 |
| Bassi, A; Beltrame, M; Blasevich, F; Bragato, C; Brix, A; Carra, S; Cotelli, F; Maggi, L; Mantegazza, R; Mora, M; Salerno, F | 1 |
2 other study(ies) available for bromopyruvate and glycogen
| Article | Year |
|---|---|
Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Energy Metabolism; Glycogen; Glycolysis; Hexokinase; Humans; Lactates; Lymphocytes; Organometallic Compounds; Oxidative Phosphorylation; Phosphofructokinase-1; Pyruvate Kinase; Pyruvates; Rats | 2012 |
Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment.
Topics: alpha-Glucosidases; Animals; Animals, Genetically Modified; Autophagy; Drug Evaluation, Preclinical; Gene Knockdown Techniques; Glycogen; Glycogen Storage Disease Type II; Glycolysis; Hexokinase; Humans; Lysosomes; Microscopy, Electron; Morpholinos; Motor Activity; Muscle, Skeletal; Pyruvates; Zebrafish; Zebrafish Proteins | 2020 |